Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
7/14/2020
Long Awaited Chinese Civil Code - Impacts on IPR
7/9/2020
Clover Biopharma Receives $66M from CEPI for COVID-19 Vaccine Candidat...
7/8/2020
Sinovac Begins Phase III Trial of Its Coronavirus Vaccine in Brazil
7/7/2020
SinoPharm Completes New Vaccine Plant in Wuhan, Doubling Capacity
7/3/2020
GSK Launches Shingles Vaccines Shingrix in China
7/1/2020
China's First COVID-19 mRNA Vaccine Approved for Clinical Trials
6/30/2020
China to Initiate Use of a Controversial Covid-19 Vaccine in Its Milit...
6/29/2020
Lee's Pharma Gains Chinese Import Approval of Unidrox Prulifloxacin Ta...
6/25/2020
Boehringer Ingelheim's China-developed CSF Live Vaccine Approved
6/25/2020
Sinovac Receives Approval from China for its Quadrivalent Influenza Va...
6/25/2020
China's Vaccine Development Enters Phase III Trial
6/23/2020
Clover Biopharma Launches Sixth Chinese COVID-19 Vaccine Trial
6/23/2020
Punitive Damages in China's New Civil Code
6/23/2020
Bio-Thera's Avastin Biosimilar Application Accepted by NMPA
6/22/2020
IMBCAMS Begins Phase II Trial of Its Covid-19 Vaccine
6/18/2020
Hua Medicine Successfully Completes SEED (HMM0301), Dorzagliatin's Pha...
6/18/2020
Innovent Announces Chinese Approval for BYVASDA (Bevacizumab Biosimila...
6/17/2020
Yisheng unveils PIKA adjuvanted recombinant protein vaccine candidate ...
6/17/2020
SinoPharm/CNBG Reports Positive Outcome of Early Data on Covid-19 Vacc...
6/16/2020
Sinovac Reports Positive Early Data of Its Covid-19 Vaccine
5/21/2020
CanSino and Precision NanoSystems Announce Collaboration to Co-Develop...
5/19/2020
Qingdao Primedicine and Primary Peptides Enter Exclusive China Partner...
5/6/2020
CEPI Signs COVID-19 Vaccine Pact with Clover Bio
4/30/2020
NMPA Solicits Comments on Seven Draft Documents on Registration and Po...
4/30/2020
CDE Solicits Comments on the Draft Rules for Linked Review and Approva...
4/30/2020
NMPA Solicits Comments on the Draft Measures for Control of Vaccine Pr...
4/23/2020
Everest Med Approved for Clinical Trial of Sacituzumab in China
4/17/2020
Dynavax and Sinovac Announce Collaboration to Develop a COVID-19 Vacci...
4/13/2020
China Approves Inactivated COVID-19 Vaccines for Clinical Trials
4/9/2020
China Recruits Volunteers for Phase 2 Coronavirus Vaccine Trial
Page:
18
/
71
Total number of articles:
2126
:
[First]
[<<]
[16]
[17]
[18]
[19]
[20]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit